Hint mode is switched on Switch off
For swift navigation between sections

Organization: Johnson&Johnson
LEI 549300G0CFPGEF6X2043

Organization name
Johnson & Johnson
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
29,594 mln USD

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Awards

News

30/08/2023 Johnson&Johnson: Results Of Operations And Financial Condition, Financial Statements And Exhibits
23/08/2023 Johnson&Johnson: Completion Of Acquisition Or Disposition Of Assets, Financial Statements And Exhibits
28/07/2023 Johnson&Johnson: Temporary Suspension Of Trading Under Registrant S Employee Benefit Plans, Financial Statements And Exhibits
24/07/2023 Johnson&Johnson: Other Events, Financial Statements And Exhibits
20/07/2023 Johnson&Johnson: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    549300G0CFPGEF6X2043
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4,500 Health Care
  • CIK
    0000200406

Credit ratings

Macroeconomic Indicators - Johnson&Johnson

Registration is required to get access.